These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20971363)

  • 1. Antiretroviral therapy in low-resource settings.
    Cainelli F; Lanzafame M; Vento S
    Lancet; 2010 Oct; 376(9750):1392. PubMed ID: 20971363
    [No Abstract]   [Full Text] [Related]  

  • 2. ART in low-resource settings: how to do more with less.
    Koole O; Colebunders R
    Lancet; 2010 Aug; 376(9739):396-8. PubMed ID: 20638119
    [No Abstract]   [Full Text] [Related]  

  • 3. The real challenges for scaling up ART in sub-Saharan Africa.
    Van Damme W; Kober K; Laga M
    AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
    [No Abstract]   [Full Text] [Related]  

  • 4. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens.
    Shannon K; Kaida A; Rachlis B; Lloyd-Smith E; Gray G; Strathdee SA
    AIDS; 2008 Sep; 22(14):1705-7. PubMed ID: 18753938
    [No Abstract]   [Full Text] [Related]  

  • 5. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
    Toro PL; Katyal M; Carter RJ; Myer L; El-Sadr WM; Nash D; Abrams EJ;
    AIDS; 2010 Feb; 24(4):515-24. PubMed ID: 19996939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of antiretroviral therapy in low-resource settings.
    Lawn SD; Bekker LG; Calmy A; Wood R
    Lancet; 2008 Jul; 372(9635):287-8; author reply 289. PubMed ID: 18657697
    [No Abstract]   [Full Text] [Related]  

  • 7. Promoting long term adherence to antiretroviral treatment.
    Mills EJ; Lester R; Ford N
    BMJ; 2012 Jun; 344():e4173. PubMed ID: 22745327
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring of antiretroviral therapy in low-resource settings.
    Bendavid E
    Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting the failure of 3 by 5.
    Brown RC; Brown JE
    Lancet; 2005 Jul 9-15; 366(9480):117-8. PubMed ID: 16005323
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting the failure of 3 by 5.
    Harries AD
    Lancet; 2005 Jul 9-15; 366(9480):117. PubMed ID: 16005322
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
    Coovadia H
    N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings.
    Phillips AN; Pillay D; Garnett G; Bennett D; Vitoria M; Cambiano V; Lundgren J
    AIDS; 2011 Mar; 25(6):843-50. PubMed ID: 21192233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directly observed therapy for HIV/tuberculosis co-infection.
    Lurie MN; Carter EJ; Cohen J; Flanigan TP
    Lancet Infect Dis; 2004 Mar; 4(3):137-8. PubMed ID: 14998498
    [No Abstract]   [Full Text] [Related]  

  • 14. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV drugs for treatment, and for prevention.
    Dabis F; Newell ML; Hirschel B
    Lancet; 2010 Jun; 375(9731):2056-7. PubMed ID: 20537377
    [No Abstract]   [Full Text] [Related]  

  • 16. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa.
    Chopra M; Kendall C; Hill Z; Schaay N; Nkonki LL; Doherty TM
    AIDS; 2006 Oct; 20(15):1975-7. PubMed ID: 16988520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa.
    Rosen S; Sanne I; Collier A; Simon JL
    Lancet; 2005 Jan 22-28; 365(9456):354-6. PubMed ID: 15664233
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting the failure of 3 by 5.
    Lancet; 2005 May 7-13; 365(9471):1597. PubMed ID: 15889458
    [No Abstract]   [Full Text] [Related]  

  • 19. When to switch for antiretroviral treatment failure in resource-limited settings?
    Vekemans M; John L; Colebunders R
    AIDS; 2007 May; 21(9):1205-6. PubMed ID: 17502731
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.